Cargando…
Cysteamine treatment restores the in vitro ability to differentiate along the osteoblastic lineage of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient
BACKGROUND: Cystinosis is a rare autosomal recessive disease caused by mutations of the CTNS gene, which encodes for a lysosomal cystine/H(+) symporter. In mice, inactivation of the CTNS gene causes intralysosomal cystine accumulation and progressive organ damage that can be reversed, at least in pa...
Autores principales: | Conforti, Antonella, Taranta, Anna, Biagini, Simone, Starc, Nadia, Pitisci, Angela, Bellomo, Francesco, Cirillo, Valentina, Locatelli, Franco, Bernardo, Maria Ester, Emma, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428230/ https://www.ncbi.nlm.nih.gov/pubmed/25947233 http://dx.doi.org/10.1186/s12967-015-0494-0 |
Ejemplares similares
-
Stem Cell Microvesicles Transfer Cystinosin to Human Cystinotic Cells and Reduce Cystine Accumulation In Vitro
por: Iglesias, Diana M., et al.
Publicado: (2012) -
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress
por: Conforti, Antonella, et al.
Publicado: (2016) -
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency
por: Starc, Nadia, et al.
Publicado: (2017) -
Genistein improves renal disease in a mouse model of nephropathic cystinosis: a comparison study with cysteamine
por: De Leo, Ester, et al.
Publicado: (2022) -
Bioengineered Cystinotic Kidney Tubules Recapitulate a Nephropathic Phenotype
por: Sendino Garví, Elena, et al.
Publicado: (2022)